Humira (Adalimumab) for Psoriasis

Overview:
- Drug Name: Adalimumab
- Brand Name: Humira
- Class: Biologics, specifically a tyrosine kinase inhibitor
- Mechanism: Inhibits tumor necrosis factor alpha (TNF-α), a chemical messenger involved in autoimmune attacks

Indications
- Psoriasis: Moderate to severe chronic plaque Show Full Answer

Humira (Adalimumab) for Psoriasis

Overview:
- Drug Name: Adalimumab
- Brand Name: Humira
- Class: Biologics, specifically a tyrosine kinase inhibitor
- Mechanism: Inhibits tumor necrosis factor alpha (TNF-α), a chemical messenger involved in autoimmune attacks

Indications:
- Psoriasis: Moderate to severe chronic plaque psoriasis
- Psoriatic Arthritis: Active psoriatic arthritis
- Combination Therapy: Can be prescribed alone or with conventional disease-modifying antirheumatic drugs (DMARDs) like methotrexate

Administration:
- Method: Subcutaneous injection
- Frequency: Every other week
- Forms: Available as a pen or prefilled syringe

Common Side Effects:
- Respiratory infections
- Headache
- Redness or irritation at injection sites
- Rash

Serious Side Effects:
- Severe infections
- Allergic and hypersensitivity reactions
- Demyelinating disease
- Heart failure
- Lupus-like syndrome
- Increased risk of certain cancers, such as lymphoma

Additional Information:
- For more details, visit: [Humira — AbbVie](https://www.humira.com)

Note: Always consult with a healthcare provider for personalized medical advice and to understand the potential risks and benefits of any treatment.

 This AI-generated response comes from MyPsoriasisTeam and other selected sources. It is not a substitute for medical advice. Always ask your doctor about specific health concerns.

Humira (Adalimumab) for Psoriasis | MyPsoriasisTeam

Injections for Psoriasis Treatment | MyPsoriasisTeam